Authors/Disclosures
|
Andrew G. Herzog, MD, MSc, FAAN
|
Dr. Herzog has nothing to disclose. |
|
Cynthia L. Harden, MD
(Xenon Pharmaceuticals Inc)
|
Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care. |
|
Joyce D. Liporace, MD
|
No disclosure on file |
|
Donald L. Schomer, MD, FAAN
(Beth Israel Deaconess Medical Center, Harvard Medical School)
|
No disclosure on file |
|
Michael R. Sperling, MD, FAAN
(Thomas Jefferson University)
|
Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium . |
|
|
No disclosure on file |
|
Wenjuan Zhang, MD
(University of Maryland Medical Center)
|
No disclosure on file |
|
|
No disclosure on file |
|
Bill Nikolov
|
No disclosure on file |
|
Melanee Newman
(Emory University School of Medicine)
|
No disclosure on file |
|
Kristen Fowler
(Beth Israel Deaconess Medical Center)
|
No disclosure on file |